Central Nervous System

Connect with us

CNS drug development norms are being challenged

Nowadays Clinical Development Programs in the Central Nervous System (CNS) reach the highest failure rates across all therapeutic areas. Unsurprisingly this had led to a challenging of accepted and established norms by CNS drug developers.

At ICON we continually invest in staff training and advanced technologies for CNS drug development to find a better way. Our innovative processes and tools including protocol design, site training, ongoing and real time data quality analysis, are all designed to maximise the probability of success.